Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
10:57:43 EDT Thu 18 Jun 2026
Enter Symbol
or Name
USA
CA



Q:TLTFF - THERALASE TECHNOLOGIES INC - https://theralase.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
TLTFF - Qnot subscribed0.17128.521260.171  0.1735  0.170.3061  0.101910:31:33Jun 0315 min RT 2¢

Recent Trades - Last 10 of 26
Time ETExPriceChangeVolume
10:31:33Q0.17 500
10:31:29Q0.17 500
10:31:29Q0.17 1,000
10:31:27Q0.17 1,500
10:31:25Q0.17 500
10:31:23Q0.17 2,500
10:31:23Q0.17 7,000
10:31:22Q0.17 1,500
10:31:20Q0.17 2,000
10:31:14Q0.17 2,500

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-06-03 07:02U:TLTFFNews ReleaseTheralase(R) Lists Warrants on the TSXV
2026-05-29 17:05U:TLTFFNews ReleaseTheralase(R) Releases Q1 2026 Financial Statements
2026-05-04 17:23U:TLTFFNews ReleaseTheralase(R) Releases 2025 Annual Financial Statements and Provides Clinical Study Update
2026-04-13 07:01U:TLTFFNews ReleaseTheralase(R) Reports Complete Response with X-Ray-Activated Rutherrin(R) in Muscle Invasive Bladder Cancer Preclinical Study
2026-04-10 07:01U:TLTFFNews ReleaseTheralase(R) Closes $CAN 2.66 Million Financing
2026-03-17 07:02U:TLTFFNews ReleaseTheralase(R) Discovers Further Mechanism on How Ruvidar(R) Inactivates Herpes Simplex Virus
2026-03-10 07:02U:TLTFFNews ReleaseTheralase(R) Closes $1.1 M Non-Brokered Private Placement
2026-03-09 07:02U:TLTFFNews ReleaseTheralase(R) Demonstrates That X-Ray-Activated Rutherrin(R) Is Significantly More Effective than Radiation Alone in the Destruction of Muscle Invasive Bladder Cancer
2026-03-02 07:02U:TLTFFNews ReleaseLight-Activated Ruvidar and Interferon Demonstrate Enhanced Efficacy
2026-02-20 07:01U:TLTFFNews ReleaseCorrecting and Replacing: Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress
2026-02-17 07:02U:TLTFFNews ReleaseTheralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress
2026-02-10 07:02U:TLTFFNews ReleaseTheralase(R) Bladder Cancer Clinical Data to be Presented at the 2026 American Urological Association Annual Meeting
2026-02-04 07:02U:TLTFFNews ReleaseTheralase(R) Provides Update on Bladder Cancer Clinical Study
2026-02-02 07:03U:TLTFFNews ReleaseTheralase(R) Completes Enrollment in Bladder Cancer Clinical Study
2026-01-12 07:02U:TLTFFNews ReleaseFerring Pharmaceuticals and Theralase(R) Technologies Announce Clinical Development Agreement to Investigate Combination Therapy in Bladder Cancer
2025-12-23 16:41U:TLTFFNews ReleaseTheralase(R) Closes $1.3 M Non-Brokered Private Placement
2025-12-12 17:01U:TLTFFNews ReleaseTheralase(R) Commences Non-Brokered Private Placement and Termination of Previously Announced Financing
2025-11-17 07:03U:TLTFFNews ReleaseTheralase(R) Investor Conference Call Reminder
2025-11-10 07:02U:TLTFFNews ReleaseTheralase(R) Releases 3Q2025 Financial Statements
2025-11-03 07:03U:TLTFFNews ReleaseTheralase(R) Demonstrates Effectiveness of X-Ray-Activated Drug